M Davy

Summary

Affiliation: SmithKline Beecham Pharmaceuticals
Country: USA

Publications

  1. ncbi Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers
    M Davy
    SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK
    Chemotherapy 45:491-5. 1999
  2. ncbi Lack of effect of gemifloxacin on the steady-state pharmacokinetics of theophylline in healthy volunteers
    M Davy
    SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK
    Chemotherapy 45:478-84. 1999

Collaborators

Detail Information

Publications2

  1. ncbi Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers
    M Davy
    SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK
    Chemotherapy 45:491-5. 1999
    ..It is concluded that the pharmacodynamic effects of warfarin are not affected by gemifloxacin, and therefore both drugs can be co-administered without dosage adjustment...
  2. ncbi Lack of effect of gemifloxacin on the steady-state pharmacokinetics of theophylline in healthy volunteers
    M Davy
    SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK
    Chemotherapy 45:478-84. 1999
    ..In conclusion, theophylline and gemifloxacin may be co-administered without any adjustment in theophylline dose...